Home > Boards > US Listed > Biotechs > Bio-Path Holdings Inc. (BPTH)

I spent way too much time detailing this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Pat Torney Member Profile
 
Followed By 0
Posts 111
Boards Moderated 0
Alias Born 03/09/15
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/2/2019 4:06:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/2/2019 10:22:49 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/27/2019 4:38:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/26/2019 4:32:06 PM
Bio-Path Holdings Announces Successful Completion of Safety Testing in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leu... GlobeNewswire Inc. - 11/26/2019 8:00:10 AM
Bio-Path Holdings Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/25/2019 2:11:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/22/2019 5:26:35 PM
Bio-Path Holdings Announces $8.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 11/21/2019 11:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/21/2019 8:21:07 AM
Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 GlobeNewswire Inc. - 11/21/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2019 7:08:27 AM
Bio-Path Holdings Reports Third Quarter 2019 Financial Results GlobeNewswire Inc. - 11/15/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:25:09 PM
Bio-Path Holdings to Announce Third Quarter 2019 Financial Results on November 15, 2019 GlobeNewswire Inc. - 11/8/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 11/1/2019 4:49:22 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/1/2019 4:46:18 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 10/22/2019 5:06:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/15/2019 4:24:51 PM
Bio-Path Holdings Appoints Martina Molsbergen to Board of Directors GlobeNewswire Inc. - 10/15/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2019 5:17:26 PM
Bio-Path Updates Intellectual Property Portfolio with Addition of Recently Issued Second Platform Technology Patent GlobeNewswire Inc. - 9/25/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/4/2019 4:07:11 PM
Bio-Path Holdings to Present at the H.C. Wainwright 21st Annual Global Investment Conference GlobeNewswire Inc. - 9/3/2019 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2019 6:02:06 AM
Bio-Path Announces Patient Dosing in Amended Phase 2 Prexigebersen Trial in Acute Myeloid Leukemia GlobeNewswire Inc. - 8/26/2019 7:00:00 AM
Pat Torney   Friday, 10/04/19 11:41:54 AM
Re: SloDan post# 6190
Post # of 6230 
I spent way too much time detailing this for everyone in the past. He has taken millions of dollars out of this company while driving it into the ground. He has been way over his head and does not have the expertise to see it through. However, PN has manipulated things so that the shareholders can't vote him out. The only hope for this company at this point is that his age will catch up with him and he will finally retire. Unfortunately, I think those who are vocal, like myself, just enrage him and make him want to stay with the company even more. A competent CEO/COB would have had some of these studies done already, with product in the market. Yet, here we are, floundering. I don't even have hardly any shares anymore because of his tricks to dilute the angry shareholders.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist